Company Filing History:
2 out of 1,217 
1 out of 28 
Years Active: 1996-1999
Title: The Innovations of Libaniel Rodriguez
Introduction
Libaniel Rodriguez is an accomplished inventor based in Elkridge, MD (US). He has made significant contributions to the field of diabetes treatment through his innovative research and development of pharmaceutical compositions. With a total of 3 patents, Rodriguez has established himself as a key figure in the medical research community.
Latest Patents
Rodriguez's latest patents include a "Method of inhibiting aldose reductase in vivo with intrinsic inhibitors." This patent describes the isolation and purification of an intrinsic aldose reductase inhibitor from mammalian cells, such as rat or human kidney cells. The intrinsic aldose reductase inhibitor can be incorporated into pharmaceutical compositions for treating conditions related to diabetes. Another notable patent is the "Process for making intrinsic inhibitors of aldose reductase," which also focuses on the isolation and purification of the inhibitor from mammalian cells for similar therapeutic applications.
Career Highlights
Throughout his career, Rodriguez has worked with prominent organizations, including the United States of America as represented by the Department of Health. His work has been instrumental in advancing the understanding and treatment of diabetes through innovative methodologies.
Collaborations
Rodriguez has collaborated with esteemed colleagues such as Peter F Kador and Yukio Takahashi. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Libaniel Rodriguez's contributions to the field of diabetes treatment through his patents and collaborations highlight his dedication to medical innovation. His work continues to impact the lives of many individuals affected by diabetes.